Phosphatidylserine-positive erythrocytes bind to immobilized and soluble thrombospondin-1 via its heparin-binding domain

Kuypers, 1998, Phospholipid asymmetry in health and disease, Curr Opin Hematol, 5, 122, 10.1097/00062752-199803000-00007 Zwaal, 1997, Pathophysiologic implications of membrane phospholipid asymmetry in blood cells, Blood, 89, 1121, 10.1182/blood.V89.4.1121 Wu, 2006, Phosphatidylserine recognition by phagocytes: a view to a kill, Trends Cell Biol, 16, 189, 10.1016/j.tcb.2006.02.003 Setty, 2002, Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion, Blood, 99, 1564, 10.1182/blood.V99.5.1564 Eda, 2002, Cytoadherence of malaria-infected red blood cells involves exposure of phosphatidylserine, Cell Physiol Biochem, 12, 373, 10.1159/000067908 Bonomini, 2002, Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure, Kidney Intl, 62, 1358, 10.1111/j.1523-1755.2002.kid560.x Hebbel, 1980, Erythrocyte adherence to endothelium in sickle-cell anemia, N Engl J Med, 302, 992, 10.1056/NEJM198005013021803 Manodori, 2000, Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin, Blood, 95, 1293, 10.1182/blood.V95.4.1293.004k42_1293_1300 Bornstein, 1995, Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1, J Cell Biol, 130, 503, 10.1083/jcb.130.3.503 Chen, 2000, The cell biology of thrombospondin-1, Matrix Biol, 19, 597, 10.1016/S0945-053X(00)00107-4 Adams, 2001, Thrombospondins: multifunctional regulators of cell interactions, Ann Rev Cell Dev Biol, 17, 25, 10.1146/annurev.cellbio.17.1.25 Elzie, 2004, The N-terminus of thrombospondin: the domain stands apart, Int J Biochem Cell Biol, 36, 1090, 10.1016/j.biocel.2003.12.012 Frazier, 1991, Thrombospondins, Curr Opin Cell Biol, 3, 792, 10.1016/0955-0674(91)90052-Z McPherson, 1981, Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture: apparent identity with platelet thrombospondin, J Biol Chem, 256, 11330, 10.1016/S0021-9258(19)68595-9 Mosher, 1982, Synthesis and secretion of thrombospondin by cultured human endothelial cells, J Cell Biol, 93, 343, 10.1083/jcb.93.2.343 Jaffe, 1983, Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix, Proc Natl Acad Sci U S A, 80, 998, 10.1073/pnas.80.4.998 Manodori, 1998, Enhanced adherence of sickle erythrocytes to thrombin-treated endothelial cells involves interendothelial cell gap formation, Blood, 92, 3445, 10.1182/blood.V92.9.3445 Gupta, 1999, Mechanism of interaction of thrombospondin with human endothelium and inhibition of sickle erythrocyte adhesion to human endothelial cells by heparin, Biochim Biophys Acta, 1453, 63, 10.1016/S0925-4439(98)00085-4 Dixit, 1986, Monoclonal antibodies that recognize calcium-dependent structures of human thrombospondin: characterization and mapping of their epitopes, J Biol Chem, 261, 1962, 10.1016/S0021-9258(17)36037-4 Dixit, 1985, A monoclonal antibody against human thrombospondin inhibits platelet aggregation, Proc Natl Acad Sci U S A, 82, 3472, 10.1073/pnas.82.10.3472 Kosfeld, 1991, Cell attachment activity of the carboxyl-terminal domain of human thrombospondin expressed in Escherichia coli, J Biol Chem, 266, 24257, 10.1016/S0021-9258(18)54222-8 Merle, 1997, Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1, J Cellular Biochem, 67, 75, 10.1002/(SICI)1097-4644(19971001)67:1<75::AID-JCB8>3.0.CO;2-T Clezardin, 1997, Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1, Biochem J, 321, 819, 10.1042/bj3210819 Kuypers, 1996, Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V, Blood, 87, 1179, 10.1182/blood.V87.3.1179.bloodjournal8731179 Setty, 2008, Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytes, Blood, 111, 905, 10.1182/blood-2007-07-099465 Setty, 2001, Thrombophilia in sickle cell disease: the red cell connection, Blood, 98, 3228, 10.1182/blood.V98.12.3228 Setty, 2001, Fetal hemoglobin in sickle cell anemia: relationship to erythrocyte adhesion markers and adhesion, Blood, 97, 2568, 10.1182/blood.V97.9.2568 Hillery, 1996, Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin, Blood, 87, 4879, 10.1182/blood.V87.11.4879.bloodjournal87114879 Raynal, 1994, Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins, Biochim Biophys Acta, 1197, 63, 10.1016/0304-4157(94)90019-1 Matsui, 2002, Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin, Blood, 100, 3790, 10.1182/blood-2002-02-0626 Barabino, 1999, Anionic polysaccharides inhibit adhesion of sickle erythrocytes to the vascular endothelium and result in improved hemodynamic behavior, Blood, 93, 1422, 10.1182/blood.V93.4.1422 Sugihara, 1992, Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells, Blood, 80, 2634, 10.1182/blood.V80.10.2634.2634 Joneckis, 1993, Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia, Blood, 82, 3548, 10.1182/blood.V82.12.3548.3548 Swerlick, 1993, Alpha 4 beta 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium, Blood, 82, 1891, 10.1182/blood.V82.6.1891.1891 Brittain, 2001, Integrin-associated protein is an adhesion receptor on sickle red blood cells for immobilized thrombospondin, Blood, 97, 2159, 10.1182/blood.V97.7.2159 Brittain, 2001, Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction, J Clin Invest, 107, 1555, 10.1172/JCI10817 Zen, 1999, Critical factors in basal cell adhesion molecule/Lutheran-mediated adhesion to laminin, J Biol Chem, 274, 728, 10.1074/jbc.274.2.728 Udani, 1998, Basal cell adhesion molecule/Lutheran protein, J Clin Invest, 101, 2550, 10.1172/JCI1204 Ugarova, 1995, Conformational changes in adhesive proteins modulate their adhesive function, Thromb Haem, 74, 253, 10.1055/s-0038-1642686 Lawler, 1983, Cooperative binding of calcium to thrombospondin: the effect of calcium on the circular dichroism and limited tryptic digestion of thrombospondin, J Biol Chem, 258, 12098, 10.1016/S0021-9258(17)44135-4 Slane, 1988, Conformational change in thrombospondin induced by removal of bound Ca2+: a spin label approach, FEBS Lett, 229, 363, 10.1016/0014-5793(88)81157-8 Speziale, 1990, Free Thiols of platelet thrombospondin: evidence for disulfide isomerization, J Biol Chem, 265, 17859, 10.1016/S0021-9258(18)38243-7 Araiso, 1995, Effects of Ca2+ and Mg2+ on dynamics of the polar head group of phosphatidylserine bilayers, Jpn J Physiol, 45, 369, 10.2170/jjphysiol.45.369 Joneckis, 1996, Glycoprotein IV-independent adhesion of sickle red blood cells to immobilized thrombospondin under flow conditions, Blood, 87, 4862, 10.1182/blood.V87.11.4862.bloodjournal87114862 Wun, 1997, Platelet activation and platelet-erythrocyte aggregation in patients with sickle cell anemia, J Lab Clin Med, 129, 507, 10.1016/S0022-2143(97)90005-6 Wun, 1999, Platelet-erythrocyte adhesion in sickle cell disease, J Investig Med, 47, 121 Hofstra, 1996, Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst, Blood, 87, 4440, 10.1182/blood.V87.10.4440.bloodjournal87104440 Adams, 1994, Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1, Mol Biol Cell, 5, 423, 10.1091/mbc.5.4.423 Hirsh, 1995, Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety, Chest, 108, 258S, 10.1378/chest.108.4_Supplement.258S Hirsh, 2001, Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety, Chest, 119, 64S, 10.1378/chest.119.1_suppl.64S Ger-Jan, 2002, Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment, Thrombosis Res, 105, 225, 10.1016/S0049-3848(02)00031-2 Chaplin, 1989, Preliminary trial of minidose heparin prophylaxis for painful sickle cell crises, East Afri Med J, 66, 574